Analystreport

Unity Biotechnology Inc (NASDAQ: UBX) was downgraded by analysts at Roth Capital from a "buy" rating to a "neutral" rating.

Unity Biotechnology, Inc.  (UBX) 
Last unity biotechnology, inc. earnings: 3/11 04:05 pm Check Earnings Report